Excellent news that 41 more junior doctors will be joining Royal Adelaide Hospital and QEH between August and November this year - including 23 doctors from the UK.

Valuable work by Dr. Meghan Turner to help counsel patients authors.elsevier.com/c/1hQ5t_V7wxRc… that leads on from 10.1093/jnci/djac130 cementing transoral robotic surgery in salvage. Useful to counsel our patients before high risk procedures. Dr. Chris Holsinger John Hardman Michael Topf MD, MSCI

Join Miss Nashreen Oozeer, Head & Neck Surgeon, for the third in the series FREE online The Royal College of Surgeons of Edinburgh seminar: ➡️Carcinoma of the unknown primary and TORS ➡️9th August 2023 19:00-20:00 BST ➡️Presentations by Somiah Siddiq & John Hardman Registration link: rcsed.ac.uk/professional-s…

The first participant was randomised in the NIHR-funded STARFISH trial today. Congratulations to the team at Royal Bolton hospital for giving us this trial milestone. ENT Integrate National Institute for Health and Care Research ENT UK

Today, 27th July 2023, is World Head and Neck Cancer day. Did you know this is the fourth most common cancer in men in the UK, with approx. 12,200 people diagnosed every year? #WHNCD2023

Congratulations to those who have been appointed to the 2023-2025 INTEGRATE committees! There were a very high number of applications, so well done to all who made the cut! This week we will be introducing our new chairs, and highlighting our previous committee’s achievements.

We would like to thank the outgoing chair John Hardman, secretary Kristijonas Milinis, and subcommittee chairs Chloe Swords, James Constable, and @johnpjrocke, as well as all members of the previous committees for all of their excellent work over the last two years!

A huge well done to the team at Luton and Dunstable University Hospital on reaching their recruitment target for EVEREST-HN 1! Thank you for all your hard work!

We are kicking off this week by introducing our new committee chairs! First up is Ed Balai who has taken on the role of Rhinology chair. Although new to INTEGRATE, his excellent research background makes us very excited for the directions he will lead the new committee!

Next up is James Arwyn-Jones 💙, our new Otology subcommittee chair. James worked in our last Otology group, delivering excellent projects including the CIRCA audit and NIHR funded The STARFISH Trial. We cannot wait to see how he and the new committee continue to build on these successes!

Next is our INTEGRATE secretary Ying Lee, who will be supporting all of our new committee's research projects. Also new to the team, Ying already has excellent collaborative research experience working as a research fellow and as an associate PI in the multi-centre HoT trial.

Next we have our new HN committee chair Alison Lim. Alison has an outstanding research background, with several publications on the application of in-clinic biopsy to reduce cancer waiting times and improve patient experience, and has many exciting ideas for our new HN committee!

Next up is the HNSCCUP study. One of the largest studies on cancer of unknown primary to date with over 900 patients, this research provided incredible insights into the investigation pathway and influence of HPV on survival in this uncommon malignancy. entintegrate.co.uk/hnsccup

Study suggests that a review of conventional histology by a second pathologist may be more beneficial than step serial sectioning in identifying unknown primary head and neck cancers. ja.ma/3thhZKc

In a UK wide study including >6000 participants, Chloe Swords and co-workers explore referral patterns for cochlear implantation vary across the UK according to ethnicity and socioeconomics. Chloe Swords ENT Integrate @SENSElabCam BCIG BSO Juniors doi.org/10.1371/journa…

Thrilled that this ENT Integrate project has been published in PLOS Medicine. A mammoth effort by all collaborators Cambridge Hearing Group manohar bance James Arwyn-Jones 💙 Kristijonas Milinis John Hardman

📅 It’s #HeadAndNeckCancerAwarenessWeek! 🎗️ We’re raising awareness about these cancers that affect over 550,000 people worldwide each year. Let's spread the word and support those impacted. #CancerAwareness #FightCancer

🚨 Did you know early detection can significantly improve outcomes for head and neck cancer? That’s why participation in studies like #EVERESTHN is so crucial. Together, we can change the future of cancer care. 💪 #HeadAndNeckCancerWeek #ResearchMatters

🌟 Calling all research sites! 🌟 EVEREST-HN feasibility to commence soon. We invite you to complete the feasibility questionnaire forms.office.com/e/sqz9ZG01xj See sneak preview of our intervention at t.ly/MCXGE More info at royalmarsden.nhs.uk/everest-hn

The STARFISH trial recently welcomed our 54th and 55th UK centres at Fairfield general and Oldham hospitals! We are still recruiting new sites to the study, and more on joining is available on the ENT Integrate and STARFISH trial websites entintegrate.co.uk/starfish